HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

4-(4-Methyl-1-piperazinyl)-7-nitro-2,1,3-benzoxadiazole 3-oxide

HCID 42640
New noteNew reactionRequest quotes
Print preview
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
58131-57-0
Standard SMILES
CN1CCN(c2ccc([N+](=O)[O-])c3no[n+]([O-])c23)CC1
InChIKey
MWFZDJLPWDCQIL-UHFFFAOYSA-N
Molecular formula
C11H13N5O4
Average molar mass
279.25 g/mol
Monoisotopic mass
279.09675391

Names & identifiers

Preferred name
4-(4-Methyl-1-piperazinyl)-7-nitro-2,1,3-benzoxadiazole 3-oxide
IUPAC
4-(4-methylpiperazin-1-yl)-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium
English name
4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide
Molecular formula
C11H13N5O4
Molecular weight
279.25

Names & synonyms

58131-57-0Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxideB2368BENZOFURAZAN, 7-(4-METHYL-1-PIPERAZINYL)-4-NITRO-, 1-OXIDEDTXSID502068584-(4-Methyl-1-piperazinyl)-7-nitro-2,1,3-benzoxadiazole 3-oxideRefChem:1069974DTXCID80129349NSC-207895NSC 207895NSC2078954-(4-methylpiperazin-1-yl)-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium
Show more names
CS-230XI-006,NSC-207895NSC-207895 (XI-006)NSC-207895 NSC207895XI-006, 10 mM in DMSOXI-006 (NSC207895)=1119MDMX Inhibitor, NSC207895
NSC 1799402,1,3-Benzoxadiazole, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxideXI-006MLS000756495NSC-1799404-(4-Methyl-1-piperazinyl)-7-nitro-benzofurazan 3-oxideNSC179940SMR000528763

Database identifiers

CAS
58131-57-0
PubChem CID
42640
DTXSID
DTXSID50206858
ChEMBL
CHEMBL1608727
UNII
63J576F4C5
Nikkaji
J1.084G

Properties

Computed structural properties

XLogP
1.2
Topological polar surface area
104 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
7
Rotatable bonds
1
Heavy atoms
20
Formal charge
0
Complexity
370

Physicochemical properties

Boiling point
487.6 · 487.6±55.0 °C(Predicted)
Density
1.64 · 1.64
storage temp.
-20 °C · Store at -20°C
solubility
Limited solubility
form
Powder
pka
6.23 · 6.23±0.42(Predicted)
color
Brown to reddish brown
SMILES
CN(CC1)CCN1C(C2=[N]([O-])ON=C23)=CC=C3[N+]([O-])=O
FDA UNII
63 J576F4C5 · 63J576F4C5
UNSPSC Code
12352200 · 12352200
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H332-H335
Precautionary statements
261 · P261-P280-P305+P351+P338
Storage Class
10 · 10-13 - German Storage Class 10 to 13

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
10-13 - German Storage Class 10 to 13
Hazard statements
H302-H315-H319-H332-H335
Precautionary statements
P261-P280-P305+P351+P338

Chemistry & industry

Applications · 2 items

DescriptionNSC 207895 is an inhibitor of the p53-binding protein MDMX. It decreases MDMX promoter activity in a reporter assay using HT-1080 cells in a concentration-dependent manner. NSC 207895 (5 μmol/L) decreases the expression and protein levels of MDMX and increases the expression of the p53 target gene CDKN1 (p21) in MCF-7 cells overexpressing MDMX. It also increases the expression of the pro-apoptotic genes PUMA, Bax, and PIG3. NSC 207895 (5 μmol/L) induces apoptosis and decreases cell viability in MCF-7 cells in a p53-dependent manner. It also induces p53-independent apoptosis in wild-type, mutated, and truncated p53 Ewing sarcoma cell lines (IC50s = 98.9-1,613, 236-299, and 121-396 nM, respectively) selectively over wild-type and p53-null osteosarcoma cells (IC50s = 3,690-5,416 and 2,143 nM, respectively).

UsesNSC-207895 is an anticancer agent and p53 activator. This compound decreases the expression of MDMX but also induced the expression of MDM2. It can also be used in pharmacological activity and therapeutic use of reviving antibiotics in relation to prepared efflux pump inhibitors that interact with AcrA, membrane fusion protein of AcrAB-TolC multidrug efflux pump.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes